# A Study of ZEN003694 in People With Squamous Cell Lung Cancer

> **NCT05607108** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 13 (estimated)

## Conditions studied

- Squamous Cell Lung Cancer

## Interventions

- **DRUG:** ZEN003694

## Key facts

- **NCT ID:** NCT05607108
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607108, "A Study of ZEN003694 in People With Squamous Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05607108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*